Tenders

Abschluss nicht exkl. AM-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Glatirameracetat in der Darreichungsform Fertigspritze (ATC-Code nach WHO: L03AX13)

110 Kv Connection Unkrlinik Cologne (Ukk)

Open-House Biologika Discount Contracts 2025-08-Denosumab

Completion not Excl. According to Section 130A (8) Sgb V by an Open House Model to the Active Ingredient Glatirameracetate in the Dosage Form Pen (Atc Code According to Who: L03ax13)

Completion not Excl. According to Section 130A (8) Sgb V by Means of an Open House Model to the Active Ingredient Glatirameracetate in the Dosage Form.

Completion not Excl. Pharmaceutical Discount Club. According to Section 130A (8) Sgb V by Means of an Open House Model to the Active Ingredient Interferon Beta-1A (Atc Code According to Who: L03ab07)

Open House Original Discount Contracts 2025-14 - Tiotropium Bromide/Olodaterol (Combination of Active Ingredients)

Completion of a Non -Exclusive Discount Agreement According to Section 130A (8) Sgb V on the Active Ingredient Latanoprost (Exclusively Individual Doses), Atc S01ee01 for the Time 01.06.2025 - 31.20227

Open House Original Discount Contracts 2025-14 - Tiotropium Bromide/Olodaterol (Combination of Active Ingredients)

Completion of a Non -Exclusive Discount Agreement According to Section 130A (8) Sgb V on the Active Ingredient Liraglutid, Atc A10bj02 for the Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)